(Q24337459)

negative regulation of substrate adhesion-dependent cell spreading

GOA release 2020-03-11

1 reference

Biochimica et Biophysica Acta

GOA release 2020-03-11

1 reference

Yannève Rolland

1

0 references

Michel Demeule

series ordinal

2

0 references

Richard Béliveau

series ordinal

3

0 references

language of work or name

English

0 references

publication date

April 2006

0 references

published in

0 references

volume

1763

0 references

issue

4

0 references

page(s)

393-401

0 references

cites work

Orally administered bovine lactoferrin systemically inhibits VEGF(165)-mediated angiogenesis in the rat

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Bovine lactoferrin inhibits tumor-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Expression of plasminogen activators and plasminogen activator inhibitor 1 in dedifferentiated chondrosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The regulation of neovascularization of matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Indispensable role of tissue-type plasminogen activator in growth factor-dependent tube formation of human microvascular endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Plasmin abrogates alpha v beta 5-mediated adhesion of a human keratinocyte cell line (HaCaT) to vitronectin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Plasmin modulators, aprotinin and anti-catalytic plasmin antibody, efficiently inhibit destruction of bovine vascular endothelial cells by choriocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Tissue-type plasminogen activator is involved in skeletal metastasis from human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Novel aspects and new roles for the serine protease plasmin.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Matrix metalloproteinases and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha 4 beta 1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Plasmin degradation of cartilage proteoglycan

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Intravitreal plasmin injection activates endogenous matrix metalloproteinase-2 in rabbit and human vitreous

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Inhibition of endothelial cell movement and tubulogenesis by human recombinant soluble melanotransferrin: involvement of the u-PAR/LRP plasminolytic system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Stimulation of cell surface plasminogen activation by membrane-bound melanotransferrin: a key phenomenon for cell invasion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Rous-Whipple Award Lecture. How tumors make bad blood vessels and stroma

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Development and disease in proteinase-deficient mice: role of the plasminogen, matrix metalloproteinase and coagulation system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Proteolysis of subendothelial adhesive glycoproteins (fibronectin, thrombospondin, and von Willebrand factor) by plasmin, leukocyte cathepsin G, and elastase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Evidence for high-molecular weight active peptides originating from porcine plasmin autolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Inhibitory effects of bovine lactoferrin on colon carcinoma 26 lung metastasis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

RGD peptides induce apoptosis by direct caspase-3 activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Human melanoma-associated antigen p97 is structurally and functionally related to transferrin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Membrane proteases in focus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Angiogenesis in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The biology of VEGF and its receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Activation of metalloproteinases and their association with integrins: an auxiliary apoptotic pathway in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of α2-antiplasmin

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The role of the membrane-bound tumour antigen, melanotransferrin (p97), in iron uptake by the human malignant melanoma cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Role of angiogenesis in tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The fibrinolytic system in neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Angiogenesis and the fibrinolytic system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Tissue cooperation in a proteolytic cascade activating human interstitial collagenase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Control of cell cycle progression by fibronectin matrix architecture

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

A novel RGD-independent cel adhesion pathway mediated by fibronectin-bound tissue transglutaminase rescues cells from anoikis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The human melanoma associated protein melanotransferrin promotes endothelial cell migration and angiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Disruption of epithelial cell-matrix interactions induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Pericellular plasmin induces smooth muscle cell anoikis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

The relevance of plasminogen activators to neoplastic growth. A review of recent literature.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Structure and function of the plasminogen/plasmin system

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Induction of lung fibroblast apoptosis by soluble fibronectin peptides.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

A sensitive and robust assay for urokinase and tissue-type plasminogen activators (uPA and tPA) and their inhibitor type I (PAI-1) in breast tumor cytosols

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

Immunohistochemical Study of Tumor Cell-associated Plasminogen Activators and Plasminogen Activator Inhibitors in Lung Carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021

VEGF and tPA co-expressed in malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBAMCR.2006.03.006

7 January 2021